Effect of sibutramine on intraocular pressure

Objective: This study evaluated the effects of sibutramine on intraocular pressure (IOP) and body-mass index (BMI). Methods: Thirty obese females (body-mass index >30 kg/m2) treated with sibutramine (10 mg/day) plus diet restriction for 3 months were included in the study. IOP, BMI, and blood...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmet Satici, MD, Nevin Yilmaz, MD, Mustafa Guzey, MD, Adil Kilic, MD
Format: Article
Language:English
Published: Philippine Academy of Ophthalmology 2006-06-01
Series:Philippine Journal of Ophthalmology
Subjects:
Online Access:https://paojournal.com/index.php/pjo/article/view/369
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: This study evaluated the effects of sibutramine on intraocular pressure (IOP) and body-mass index (BMI). Methods: Thirty obese females (body-mass index >30 kg/m2) treated with sibutramine (10 mg/day) plus diet restriction for 3 months were included in the study. IOP, BMI, and blood biochemical parameters were measured at the beginning and end of the treatment. Results were evaluated statistically by paired t-test, analysis of variance, and least-significant difference test. Results: A statistically significant decrease was observed in the mean body-mass index (p < 0.001) and serum triglyceride (p < 0.001), while a statistically insignificant increase was observed in IOP (p = 0.54). Conclusion: While sibutramine provided an effective means for weight loss, it caused a slight increase in IOP, although this was not statistically significant. Nevertheless, it is prudent to monitor IOP in selected obese patients treated with sibutramine.
ISSN:0031-7659